State of Medtech

State of Medtech

Health EN ↓ Epizody: 433

State of Medtech is the #1 podcast in medtech and medical devices. Hosted by Omar M. Khateeb, we go inside the business and science of healthcare innovation—with unfiltered interviews from top investors, startup founders, and industry leaders. Each week, we feature candid interviews with:💼 Top medtech investors & VCs🧠 Founders of disruptive medical device startups🧬 Clinicians & industry leaders shaping the future of medicineFrom go-to-market to M&A, AI to surgical robotics, this is your edge for scaling, funding, and selling in medtech. New episodes weekly.

Určitě navštivte web podcastu a podpořte jeho tvůrce: podcasters.spotify.com

Autor

State of Medtech

Kategorie

Health

Web podcastu

podcasters.spotify.com

Nejnovější epizoda

18. lis 2026

Kde poslouchat?

Podcasty v aplikaci Replaio Radio Už brzy

Podcasty míří do aplikace už brzy. Nainstaluj si ji teď a jako první uvidíš úplně nový pohled na podcasty

Stáhnout z Google Play Nainstaluj zdarma Android 10 mil.+ stažení · hodnocení 4,7+ iOS už brzy

Epizody

433. NeuroTech: Matt Angle of Paradromics and Babar Khan of NEOM Investment Fund on BCI and State of Venture in NeuroTech 18.11.2026

BCIs are moving from labs toward clinical systems that translate neural activity into digital communication. Omar Khateeb joins Matt Angle of Paradromics and Babar Khan of NEOM Investment Fund to explore what BCI could mean for MedTech, AI, investment, healthcare, and computing. Matt explains how Paradromics is developing high-data-rate implantable BCIs to restore speech for people with severe mot...

432. AI-Powered MedTech Commercialization with Skylar Talley of MedScout and Matt Wallace of Magnus Medical 16.11.2026

The MedTech sales rep of the future may need fewer relationships and more intelligence at their fingertips. Omar Khateeb sits down with Skylar Talley, Co-Founder and CEO of MedScout, and Matt Wallace, Vice President of Sales at Magnus Medical, to explore how AI, commercial data, and new workflows are changing MedTech sales. Matt explains how medical device selling is shifting from relationship-hea...

431. Marketing: Why you must turn Sales and Marketing in to a Single Revenue Team 13.11.2026

The test of MedTech marketing is not attention. It is whether the market is moving toward adoption. Omar Khateeb explains how MedTech marketing can drive physician adoption, utilization, pipeline velocity, and revenue growth. He revisits the adoption curve to show why early adopters and mainstream physicians respond differently. Broader adoption often requires clinical evidence, peer validation, e...

430. Endoscopic Metabolic Restoration: Aqua Medical’s New Approach to Type 2 Diabetes with Bob Haggerty 09.11.2026

Type 2 diabetes has long been managed through medication, injections, lifestyle changes, and GLP-1 therapies. Aqua Medical is investigating whether endoscopy could add another option. Omar Khateeb sits down with Bob Haggerty, CEO of Aqua Medical, to explore Endoscopic Metabolic Restoration and its investigational PIMA procedure. PIMA delivers radiofrequency-generated water vapor through a standard...

429. Intuitive Ventures Playbook: $5M to $10M Bets, Clinical Evidence and Market Creation with Terri Burke 04.11.2026

What makes a medical technology worth backing with millions? Omar Khateeb sits down with Terri Burke, Senior Partner at Intuitive Ventures, to explore how the fund evaluates MedTech and healthcare innovation. Terri draws on 30+ years as an operator, founder, and investor. Intuitive Ventures invests from seed through growth, with initial checks of $5 million to $10 million. She explains why strong...

428. Cardio: How AI Is Fighting Heart Attacks: Coronary Inflammation, Plaque & Heart Attack Prevention | Steve Deitsch 02.11.2026

The biggest opportunity in cardiovascular AI may come from revealing risk that conventional imaging does not fully explain. Omar Khateeb sits down with Steve Deitsch, CEO of Caristo Diagnostics, to discuss CaRi-Heart, an FDA-authorized AI technology that quantifies coronary inflammation from routine CCTA imaging. Before Caristo, Steve served as CFO of OrganOx and helped lead its $1.5 billion acqui...

427. This Month in MedTech: Stryker’s $400M Robotics Bet on CMR, J&J’s $400M Reset and the New Strategic Playbook with Henry Peck, CBO at LSI 28.10.2026

In this episode, Omar Khateeb sits down with Henry Peck, Chief Business Officer at LSI, for a September and October edition of This Month in MedTech covering major exits, surgical robotics, regulatory shifts, and strategic capital. More than $4 billion in European MedTech exits set the stage. Henry shares LSI data showing that 77% of more recent LSI Europe companies are pursuing an FDA-first pathw...

426. TechMed: Could the Next Billion-Dollar MedTech Companies Be Built Like Silicon Valley Startups? with Nick Damiano of Andromeda Surgical and Dave Messina of Pioneer Fund 26.10.2026

MedTech may be entering an era where the most valuable companies are built as platforms. Omar Khateeb sits down with Nick Damiano of Andromeda Surgical and Dave Messina of Pioneer Fund to explore TechMed, autonomous surgery, VC, and startups. Nick explains how software, regulation, focused use cases, and rapid feedback can make MedTech more scalable. Andromeda starts narrow and builds toward broad...

425.a16z State of Markets 2026: Why MedTech Could Be the Next Big Investment Opportunity 23.10.2026

a16z says physical technology is becoming important again. What could that mean for MedTech? Omar Khateeb analyzes a16z’s State of Markets 2026 report and explores how AI, robotics, infrastructure, and changing venture economics could reshape the investment case for medical technology. One theme stands out: capital is moving into industries that require hardware, manufacturing, infrastructure, and...

424. Space Medicine: Designing Healthcare for Life Beyond Earth with Matthew Kuhn of Skybound Medtech 19.10.2026

Space exploration may be approaching a bottleneck: the human body. Omar Khateeb speaks with Matthew Kuhn, CEO of Skybound Medtech, to explore space medicine, autonomous care and robotics. Microgravity accelerates muscle and bone loss, while deep-space communication delays can make real-time support from Earth impractical. They discuss autonomous surgery, physical AI, reusable devices, remote diagn...

423. Scalable Surgery: Predictability, Efficiency and the ASC Opportunity with Jeffery Alvarez of Moon Surgical 14.10.2026

Surgical demand keeps rising, but the answer may not be more rooms, staff, or complex robotic systems. Omar Khateeb sits down with Jeffery Alvarez, Chief Strategy Officer at Moon Surgical, to explore Scalable Surgery and how physical AI, workflow design, and ASC economics could reshape surgical robotics. Jeffery explains why healthcare needs better execution, not simply more capacity. ASCs use spe...

422. Remote Surgery and the New Infrastructure of Healthcare with Brian Miller of SOVATO 12.10.2026

Remote surgery becomes far more interesting when you stop thinking about moving a robot and start thinking about moving expertise. In this episode, Omar Khateeb sits down with Brian Miller, CEO of SOVATO, to explore how remote procedures could reshape specialized care. Brian explains why robotics is only one part of the equation. It depends on secure infrastructure, reliable connectivity, clinical...

421. Career: Omar M. Khateeb on building a career in medtech, the state of venture capital and more 07.10.2026

In this episode, Jacob McLaughlin welcomes Omar Khateeb for a conversation about medical device sales, MedTech leadership, entrepreneurship, market strategy, and building long-term career leverage. Omar shares how his career evolved from surgical robotics and medical device sales into marketing, Silicon Valley, entrepreneurship, and MarketCraft, where he focuses on MedTech market engineering for e...

420.Surgical Robotics: Expanding Global Access Through Telesurgery with Sudhir Srivastava, MD of SS Innovations 05.10.2026

In this episode, Omar Khateeb speaks with Sudhir Srivastava, MD, Founder, Chairman & CEO of SS Innovations International Inc., on how surgical robotics and telesurgery could reshape access to care. Dr. Srivastava shares his journey from cardiac surgeon to MedTech founder and the development of the SSi Mantra surgical robotic platform, built to make robotic surgery more affordable and accessibl...

419.MedTech Venture Growth: Becoming Magnetic to Capital, Clinicians and Talent 30.09.2026

In this solo episode, Omar Khateeb explains why MedTech founders should stop treating social media like traditional marketing and start using it as a market engineering tool to build investor demand, clinical credibility, strategic awareness, and talent attraction. Most companies begin outreach only when they need something. Investors hear from the company during a fundraise, physicians when adopt...

418. Venture Capital: Jenny Barba and Jeff Chu of Features Capital 28.09.2026

In this episode, Omar Khateeb speaks with Jenny Barba and Jeff Chu, Co-Founders, Features Capital, about what makes an early-stage MedTech company investable before first-in-human data or meaningful revenue. Features Capital often invests $500,000 to $2 million at this stage. Jenny and Jeff explain why investors look beyond technology to founder execution, technical feasibility, clinical adoption,...

417. Unlocking Capital for Medtech Through QSBS 23.09.2026

In this solo episode, Omar Khateeb explores why QSBS could become an overlooked capital formation tool in MedTech . QSBS was created to encourage investment in small American businesses, and Omar explains why it may fit MedTech investing well. Medical device companies often require years of engineering, clinical development, FDA review, reimbursement, manufacturing, and commercialization before in...

416. Venture Capital: Aneta Sottil of Andera Partners on Building MedTech Companies Investors Can Scale 21.09.2026

In this episode, Omar Khateeb speaks with Aneta Sottil, Partner at Andera Partners, about what makes a MedTech company investable as the investment bar continues to rise. Aneta explains why early data is often no longer enough. Investors increasingly want stronger clinical validation, a clear path to market, reimbursement strategy, and proof that a technology can meaningfully improve patient care....

415. Urology Venture Capital: AUA Nexus with Gavin Leonard of MedTech Syndicates and Steven Kaplan MD of the American Urological Association 17.09.2026

Explore Showpad's VIP event, Excellence in the Field, in New York on October 8, 2026, for revenue leaders seeking practical AI and sales insights. Learn more . In this episode, Omar Khateeb speaks with Gavin Leonard, CEO of MedTech Syndicates, and Steven Kaplan, Director of the American Urological Association Innovation Nexus, to explore how clinical insight, capital and commercialization can...

414. Corporate Venture:Virginia Giddings of Edwards Lifesciences on the MedTech Innovation Journey 14.09.2026

In this episode, Omar Khateeb speaks with Virginia Giddings, Vice President of Exploration at Edwards Lifesciences , about how major MedTech companies evaluate startups before commercial scale. Virginia explains why Edwards builds early relationships in structural heart and heart failure, assessing patient need, clinical evidence, reimbursement, and strategic fit. She shares why founders need conv...

413. Cardiovascular Innovation at Scale: David Hochman of Orchestra BioMed on Medtronic, AVM Therapy and Strategic Partnerships 08.09.2026

In this episode, Omar Khateeb speaks with David Hochman, Chairman & CEO of Orchestra BioMed, about a partnership-driven model for building, funding, and commercializing MedTech innovation. Orchestra focuses on intellectual property, clinical development, and pivotal execution while partnering with global strategics that already have the infrastructure to manufacture, commercialize, and scale....

412.This Month in MedTech: Physical AI, Strategic M&A and the Evolution of Intelligent Medical Devices 03.09.2026

In this episode of This Month in MedTech, Omar Khateeb speaks with Henry Peck, CBO at LSI | Intelligence, about the technologies, deals, and shifts shaping MedTech. They examine Vitestro’s FDA authorization for autonomous blood draws, bringing physical AI into a high-volume workflow within the roughly $220 billion clinical laboratory services market. The technology could expand capacity, improve a...

411. Venture: Eric S. Heinz of Heinz Ventures 31.08.2026

In this episode, Omar Khateeb speaks with Eric S. Heinz, Founder and Managing Partner of Heinz Ventures, about creating MedTech value through product development, financing, commercialization, and strategic acquisition. Eric brings 25 years of experience at Medtronic and Intuitive Surgical. His operating and M&A background shapes how he evaluates pre-seed and seed-stage companies. A major them...

410. Physical AI Could Make MedTech the Next Big AI Opportunity 26.08.2026

In this solo episode, Omar Khateeb examines why healthcare could become one of the most important beneficiaries of the next phase of AI, even as investors increasingly view the sector as a defensive alternative to the AI infrastructure trade. The central distinction is between building intelligence and deploying intelligence . Healthcare already produces enormous amounts of medical imaging, ECG da...

409. How NVIDIA Is Building the Virtual Training Ground for Medical Robots with David Niewolny 24.08.2026

In this episode, David Niewolny, Sr. Director and Global Head of Business Development for Healthcare and Medical at NVIDIA , joins Omar Khateeb to discuss how simulation, AI, open-source development, and GPU-scale computing are changing the way medical robots are built and trained. Healthcare robotics has an experience problem. Anatomy varies between patients, devices bend and interact with tissue...

Poslouchej podcast State of Medtech v Replaio

Rádio a podcasty v jedné aplikaci - zdarma a bez registrace. Nainstaluj si ji ještě dnes a nepropásni premiéru

Stáhnout z Google Play

Replaio není vydavatelem podcastů; názvy pořadů, obálky a audio patří jejich autorům a šíří se přes veřejné RSS kanály